InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,011.12
(
-0.22%
)
US TECH 100
16,833.60
(
-0.61%
)
Dow Jones
37,775.38
(
0.06%
)
Brent Oil
85.76
(
-0.76%
)
Bitcoin
64,907.79
(
2.20%
)
Post# of 48180
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

scion

Send PM Follow Ignore
Followers 245
Posts 55847
Boards Moderated 12
Alias Born 04/12/2001

scion

Member Level

Re: scion post# 48055

Thursday, 12/02/2021 11:22:57 AM

Thursday, December 02, 2021 11:22:57 AM

Post# of 48180
Sotrovimab: New COVID drug which cuts risk of hospitalisation and death by 79% approved for use in UK in people aged 12 years and older

Xevundy, also known as sotrovimab, has been approved for anyone aged 12 and over, who weighs more than 40kg. It is authorised for use in people who have a mild or moderate COVID infection and who are at risk of developing severe illness

Thursday 2 December 2021 13:12, UK
- more
https://news.sky.com/story/sotrovimab-new-covid-drug-which-cuts-risk-of-hospitalisation-and-death-by-79-approved-for-use-in-uk-in-people-aged-12-years-and-older-12484329
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up